Cargando…
Home vision monitoring in patients with maculopathy: current and future options for digital technologies
Patients with macular pathology, including that caused by age-related macular degeneration and diabetic macular oedema, must attend frequent in-clinic monitoring appointments to detect onset of disease activity requiring treatment and to monitor progression of existing disease. In-person clinical mo...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042418/ https://www.ncbi.nlm.nih.gov/pubmed/36973405 http://dx.doi.org/10.1038/s41433-023-02479-y |
_version_ | 1784912931658399744 |
---|---|
author | Balaskas, Konstantinos Drawnel, Faye Khanani, Arshad M. Knox, Paul C. Mavromaras, George Wang, Yi-Zhong |
author_facet | Balaskas, Konstantinos Drawnel, Faye Khanani, Arshad M. Knox, Paul C. Mavromaras, George Wang, Yi-Zhong |
author_sort | Balaskas, Konstantinos |
collection | PubMed |
description | Patients with macular pathology, including that caused by age-related macular degeneration and diabetic macular oedema, must attend frequent in-clinic monitoring appointments to detect onset of disease activity requiring treatment and to monitor progression of existing disease. In-person clinical monitoring places a significant burden on patients, caregivers and healthcare systems and is limited in that it only provides clinicians with a snapshot of the patient’s disease status. The advent of remote monitoring technologies offers the potential for patients to test their own retinal health at home in collaboration with clinicians, reducing the need for in-clinic appointments. In this review we discuss visual function tests, both existing and novel, that have the potential for remote use and consider their suitability for discriminating the presence of disease and progression of disease. We then review the clinical evidence supporting the use of mobile applications for monitoring of visual function from clinical development through to validation studies and real-world implementation. This review identified seven app-based visual function tests: four that have already received some form of regulatory clearance and three under development. The evidence included in this review shows that remote monitoring offers great potential for patients with macular pathology to monitor their condition from home, reducing the need for burdensome clinic visits and expanding clinicians’ understanding of patients’ retinal health beyond traditional clinical monitoring. In order to instil confidence in the use of remote monitoring in both patients and clinicians further longitudinal real-world studies are now warranted. |
format | Online Article Text |
id | pubmed-10042418 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-100424182023-03-28 Home vision monitoring in patients with maculopathy: current and future options for digital technologies Balaskas, Konstantinos Drawnel, Faye Khanani, Arshad M. Knox, Paul C. Mavromaras, George Wang, Yi-Zhong Eye (Lond) Review Article Patients with macular pathology, including that caused by age-related macular degeneration and diabetic macular oedema, must attend frequent in-clinic monitoring appointments to detect onset of disease activity requiring treatment and to monitor progression of existing disease. In-person clinical monitoring places a significant burden on patients, caregivers and healthcare systems and is limited in that it only provides clinicians with a snapshot of the patient’s disease status. The advent of remote monitoring technologies offers the potential for patients to test their own retinal health at home in collaboration with clinicians, reducing the need for in-clinic appointments. In this review we discuss visual function tests, both existing and novel, that have the potential for remote use and consider their suitability for discriminating the presence of disease and progression of disease. We then review the clinical evidence supporting the use of mobile applications for monitoring of visual function from clinical development through to validation studies and real-world implementation. This review identified seven app-based visual function tests: four that have already received some form of regulatory clearance and three under development. The evidence included in this review shows that remote monitoring offers great potential for patients with macular pathology to monitor their condition from home, reducing the need for burdensome clinic visits and expanding clinicians’ understanding of patients’ retinal health beyond traditional clinical monitoring. In order to instil confidence in the use of remote monitoring in both patients and clinicians further longitudinal real-world studies are now warranted. Nature Publishing Group UK 2023-03-27 2023-10 /pmc/articles/PMC10042418/ /pubmed/36973405 http://dx.doi.org/10.1038/s41433-023-02479-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Article Balaskas, Konstantinos Drawnel, Faye Khanani, Arshad M. Knox, Paul C. Mavromaras, George Wang, Yi-Zhong Home vision monitoring in patients with maculopathy: current and future options for digital technologies |
title | Home vision monitoring in patients with maculopathy: current and future options for digital technologies |
title_full | Home vision monitoring in patients with maculopathy: current and future options for digital technologies |
title_fullStr | Home vision monitoring in patients with maculopathy: current and future options for digital technologies |
title_full_unstemmed | Home vision monitoring in patients with maculopathy: current and future options for digital technologies |
title_short | Home vision monitoring in patients with maculopathy: current and future options for digital technologies |
title_sort | home vision monitoring in patients with maculopathy: current and future options for digital technologies |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042418/ https://www.ncbi.nlm.nih.gov/pubmed/36973405 http://dx.doi.org/10.1038/s41433-023-02479-y |
work_keys_str_mv | AT balaskaskonstantinos homevisionmonitoringinpatientswithmaculopathycurrentandfutureoptionsfordigitaltechnologies AT drawnelfaye homevisionmonitoringinpatientswithmaculopathycurrentandfutureoptionsfordigitaltechnologies AT khananiarshadm homevisionmonitoringinpatientswithmaculopathycurrentandfutureoptionsfordigitaltechnologies AT knoxpaulc homevisionmonitoringinpatientswithmaculopathycurrentandfutureoptionsfordigitaltechnologies AT mavromarasgeorge homevisionmonitoringinpatientswithmaculopathycurrentandfutureoptionsfordigitaltechnologies AT wangyizhong homevisionmonitoringinpatientswithmaculopathycurrentandfutureoptionsfordigitaltechnologies |